STAN AND JODI ROSS CHOSE TO HELP FUND PILOT TRIALS IN THE GROWING AREA OF NEUROMODULATION
|Stan and Jodi Ross with Dr. Ali Rezai, the Stanley D. and Joan H. Ross Chair in Neuromodulation in The Ohio State University Wexner Medical Center’s Department of Neurological Surgery.
Jodi and Stan Ross, co-chairs of the neuroscience campaign committee, got involved with The Ohio State University Wexner Medical Center’s Department of Neurology after their son, Malcolm, was injured in a single seat, open-wheel racecar accident at the Indianapolis Raceway Park.
Malcolm was transported by Life Flight to a hospital in Indianapolis, where he received care and treatment for a month before transferring to Ohio State’s Dodd Hall for in-patient rehabilitation. A team of neurologists, physical therapists, and other medical professionals at Ohio State helped Malcolm complete his recovery. The Rosses were thankful for the positive outcome.
A meeting with Ohio State’s Dr. Ali Rezai, a pioneer in the area of deep brain stimulation, compelled the Rosses to fund the Stanley D. and Joan H. Ross Chair in Neuromodulation in The Ohio State University Wexner Medical Center’s Department of Neurological Surgery. The Rosses discovered that by giving to Ohio State, they could make a difference in many lives.
“After meeting Dr. Ali Rezai, we knew straight away that he is a very impressive person doing very impressive things,” said Stan Ross.
Dr. Rezai, Director of the Center for Neuromodulation, uses deep brain stimulation, or “neuromodulation,” to deliver electrical signals directly to a patient’s nervous system to alleviate symptoms of conditions that result in chronic physical, emotional, behavioral, and cognitive impairment. Patients suffering from Parkinson’s, tremors, epilepsy, chronic pain, and obsessive-compulsive disorder have benefitted from neuromodulation.
Dr. Rezai and his team are also collaborating with other Ohio State specialists to develop brain pacemaker treatment approaches for patients with severe and disabling depression, traumatic brain injury, addiction, obesity, Alzheimer’s, post-traumatic stress disorder, and other neurological disorders.
The positive personal and social impacts that this type of treatment offers has the potential to permeate every quarter of society, but the practice of neuromodulation is in its infancy, which can make fundraising complex.
“Historically, it’s difficult to obtain federal funding for new clinical trial innovations like neuromodulation, so pioneer donor support like the kind provided by Stan and Jodi is critical to helping us advance the field,” said Dr. Rezai. “Donors like Stan and Jodi provide seeds to fund pilot trials that can grow into larger grants from the National Institutes of Health and other sources.”
“Dr. Rezai is a terrific guy as an individual, but his work is the tipping point. He and his team have made incredible strides and have alleviated a lot of suffering, and we are very happy to support that,” said Stan.